Skip to content

The clinical efficacy of Eight Methods of Linggui using Conception Vessel acupoints in treating primary hypothyroidism with Spleen and Kidney Yang vacuity

The clinical efficacy of Eight Methods of Linggui using Conception Vessel acupoints in treating primary hypothyroidism with Spleen and Kidney Yang vacuity

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000181
Enrollment
Unknown
Registered
2024-08-07
Start date
2023-05-28
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidism

Interventions

Linggui group:Acupuncture with point slection based on Lingguibafa Method
control group:Oral levothyroxine daily
conventional acupuncture group:acupuncture

Sponsors

Chongqing Jiulongpo Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: i. patient should meet the diagnostic criteria in "Clinical Guideline of Adult hypothyroidism (2017ed.)"; ii. patient should meet the diagnostic criteria of hypothyroidism with Spleen and Kidney Yang deficiency in "Guiding Principles of Clinical Study on New Drugs of Traditional Chinese Medicine (2002 ed.)"; iii. patient should not have taken any antidepression medication within the last 4 weeks; iv. patient should participate in this study voluntarily, and sign an informed consent.

Exclusion criteria

Exclusion criteria: Patients will be excluded from the study if they meet any of the following criteria: i. patient refuses to give informed consent ii. Severe systemic disease including cardiovascular, cerebrovascular, liver, kidney,and blood system diseases; iii. Severe diabetes; iv. Patient in pregnancy, lactation, or in preparation of pregnancy; v. Patient cannot comply with the treatment; vi. Patient difficult to communicate with due to psychological condition or dysphasia. vii. Patient plans to move or travel in the near future.

Design outcomes

Primary

MeasureTime frame
TCM symptoms questionnaire;thyroid hormone ;ThyPro;

Countries

China

Contacts

Public ContactXinxian Shao

Chongqing Jiulongpo Traditional Chinese Medicine Hospital

270134490@qq.com+86 189 9637 5949

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026